Roche Holding AG (Roche Holding AG) FCF Yield % : 6.72 (As of Apr. 27, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Roche Holding AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Roche Holding AG's Trailing 12-Month Free Cash Flow is $12,965 Mil, and Market Cap is $192,933 Mil. Therefore, Roche Holding AG's FCF Yield % for today is 6.72%.

The historical rank and industry rank for Roche Holding AG's FCF Yield % or its related term are showing as below:

RHHBY' s FCF Yield % Range Over the Past 10 Years
Min: 3.62 Med: 5.82 Max: 7.73
Current: 6.72

During the past 13 years, the highest FCF Yield % of Roche Holding AG was 7.73%. The lowest was 3.62%. And the median was 5.82%.

RHHBY's FCF Yield % is ranked better than
83.89% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.65 vs RHHBY: 6.72

Roche Holding AG's FCF Margin % for the quarter that ended in Dec. 2023 was 18.51%.

Roche Holding AG FCF Yield % Historical Data

The historical data trend for Roche Holding AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG FCF Yield % Chart

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

6.39

4.47

5.39

5.68

5.73

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															6.76	5.51	5.24	5.39	5.53

Competitive Comparison of Roche Holding AG's FCF Yield %

For the Drug Manufacturers - General subindustry, Roche Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's FCF Yield % falls into.

Roche Holding AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Roche Holding AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	13235.431	/	231072.7662
	=	5.73%

Roche Holding AG's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	6385.291	*	2	/	231072.7662
	=	5.53%

Roche Holding AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Roche Holding AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.